The incidence of RAS mutations in CRC is about 53% [78], mainly in codons 12 or 13 of exon 2 (81–96% of all KRAS mutations), and 4–19% at exon 3 or exon 4 [66,79,80]. Here, KRAS is linked to colorectal carcinoma.